Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A cancer that involves the UBERON:0016632.
Biomarker and diagnostic research for cancer of isthmus of fallopian tube has been reported in the published literature.
No clinical trials have been registered for cancer of isthmus of fallopian tube.
5 publications have been identified in PubMed for cancer of isthmus of fallopian tube. Research spans Basic Science / Preclinical (60%), Diagnostic / Biomarker (20%), and Case Report / Case Series (20%).
Roy O (2026). [PMID: 41677632](https://pubmed.ncbi.nlm.nih.gov/41677632/). *Cells*. [Basic Science / Preclinical]
Sipes J (2025). [PMID: 40158048](https://pubmed.ncbi.nlm.nih.gov/40158048/). *Communications biology*. [Basic Science / Preclinical]
Obata E (2025). [PMID: 40662005](https://pubmed.ncbi.nlm.nih.gov/40662005/). *Cureus*. [Case Report / Case Series]
Neville C (2025). [PMID: 41253950](https://pubmed.ncbi.nlm.nih.gov/41253950/). *Scientific reports*. [Basic Science / Preclinical]
Malone J (2024). [PMID: 39518057](https://pubmed.ncbi.nlm.nih.gov/39518057/). *Cancers*. [Diagnostic / Biomarker]
Data assembled from 2 of 12 sources · Last updated Sep 20, 2026, 9:37 PM UTC
AI-curated news mentioning cancer of isthmus of fallopian tube
Updated Sep 10, 2026
Sapanisertib shows promise for treating rare mTOR-driven disorders, with potential applications in various cancers including bladder and ovarian cancer. Successful late-stage clinical development could unlock orphan-drug incentives and enhance adoption in specialized treatment centers.